Illustrative calculation: an adult with episodic wheeze has a pre-bronchodilator FEV₁ of 1.60 L and a post-bronchodilator FEV₁ of 1.82 L. The increase is 220 mL and 13.8% from baseline, so both parts of the adult response criterion are met. A second illustrative result improves from 2.40 L to 2.62 L: the same 220-mL gain, but only 9.2%, so the result does not meet both parts.
The board trap is treating bronchodilator responsiveness as a single number—or treating it as a diagnosis. The more useful question is: what does a positive response support, what does a negative response fail to prove, and what should family medicine do next when the history and spirometry disagree?
Start with the two-part calculation
Spirometry first assesses maneuver quality and baseline expiratory airflow; the FEV₁/FVC ratio and other measures help determine whether airflow obstruction is present. Bronchodilator testing asks a different question: does expiratory airflow vary after a short-acting bronchodilator?
For adults with typical asthma symptoms, current asthma guidance uses an increase in FEV₁ or FVC of at least 12% and at least 200 mL from baseline after bronchodilator administration. A common protocol measures lung function 10–15 minutes after 200–400 mcg of albuterol or an equivalent drug, following the testing laboratory’s instructions.
Calculate both values yourself:
- Absolute change: post-bronchodilator value − pre-bronchodilator value
- Percentage change: absolute change ÷ pre-bronchodilator value × 100
| Pre → post FEV₁ | Absolute change | Percentage change | Interpretation |
|---|---|---|---|
| 1.60 → 1.82 L | +220 mL | 13.8% | Meets both adult thresholds |
| 2.40 → 2.62 L | +220 mL | 9.2% | Volume threshold met; percentage threshold not met |
| 1.50 → 1.67 L | +170 mL | 11.3% | Percentage is substantial; volume threshold not met |
Use the pre-bronchodilator value as the denominator. Do not calculate the percentage from the post-bronchodilator value, and do not substitute percent predicted when the question is testing the classic adult asthma criterion.
One source of confusion is that a newer general lung-function interpretive standard uses a change greater than 10% of the predicted value for bronchodilator responsiveness. That framework is not interchangeable with the asthma-diagnosis criterion. When a question asks whether an adult’s result supports asthma, identify the clinical framework being tested and apply both parts of the asthma criterion rather than mixing denominators.
A positive response supports asthma; it does not prove it
Asthma diagnosis is based on a compatible pattern of variable respiratory symptoms plus evidence of variable expiratory airflow. A positive bronchodilator response is one way to document that airflow variability. In a patient with a convincing history of variable respiratory symptoms, it makes asthma more likely, but it is not by itself sufficient to diagnose asthma and it need not be present on every test.
The baseline history should assess more than the presence of wheeze. Ask whether symptoms vary over time, worsen at night or on waking, follow exercise, cold air, allergens, laughter, or viral infections, and improve between episodes. Functional history matters: document exercise tolerance, missed work or school, sleep interruption, rescue-inhaler use, and prior urgent visits or steroid-treated exacerbations.
Also consider smoking or vaping exposure, occupational irritants, allergic rhinitis, eczema, childhood respiratory symptoms, medication use, and the patient’s response to prior treatment. These details provide the pretest probability that gives a spirometry result meaning.
A positive response is not specific to asthma; it can occur in other obstructive lung diseases. Conversely, many patients with asthma will not show a positive response during one office test. The response is therefore a piece of evidence, not a self-authenticating label.
The correct interpretation is usually: this result supports variable airflow limitation consistent with asthma in the right clinical setting—not: this number proves asthma.
Let a negative test redirect the workup, not end it
A negative bronchodilator test means that this test did not demonstrate the required degree of change under those conditions. It does not establish that the patient cannot have asthma.
Before lowering the probability of asthma, review four issues:
- Was the maneuver technically adequate? Poor effort, early termination, coughing, or inadequate repeatability can obscure a real response.
- Were bronchodilators withheld according to the laboratory protocol? Recent short-acting or long-acting bronchodilator use can reduce the measured change.
- Was the patient tested during a symptomatic period? Asthma varies; a patient may have near-normal lung function between episodes.
- Does the history still sound typical? A strong pattern of variable symptoms deserves more weight than one nondiagnostic test.
If suspicion remains high, reasonable next evidence may include repeat spirometry during symptoms, serial peak-flow monitoring, or bronchial challenge testing in an appropriate setting. Current guidance describes excessive adult peak-flow variability as an average diurnal variation greater than 10% over 1–2 weeks; when spirometry is unavailable, an increase in peak flow of at least 20% after bronchodilator can support variable airflow. These are alternative routes to demonstrating variability, not interchangeable calculations for every question.
The same logic applies when baseline spirometry is normal. Normal results between episodes do not erase a history of nocturnal, exercise-related, allergen-related, or viral-triggered symptoms. Reassess the timing of testing and the differential diagnosis rather than forcing a binary asthma-versus-no-asthma conclusion.
The reasoning errors that cost points
Using OR instead of AND. A 15% increase that is only 150 mL does not meet the adult two-part criterion. A 250-mL increase that is only 9% does not meet it either.
Using the wrong denominator. Percentage change is calculated from the patient’s pre-bronchodilator value. The same absolute improvement can be diagnostically meaningful in a smaller baseline FEV₁ and insufficient in a larger one.
Confusing reversibility with normalization. The FEV₁ does not have to become normal for the response criterion to be met. Conversely, a normal post-bronchodilator ratio does not replace the required calculation.
Treating the test as bidirectional. A positive result can support asthma, but a negative result does not exclude it. This is a classic asymmetry error: evidence that increases probability is mistakenly treated as evidence that must be present for the disease to exist.
Ignoring the patient behind the numbers. If the stem gives an episodic symptom pattern, exposure history, and functional limitation, those details are part of the diagnostic test. Do not reduce the case to the spirometer display.
A realistic revision exercise: calculate, classify, act
Close your notes and give yourself 10 minutes. For each result, write three brief answers:
- Does it meet both adult thresholds?
- Does it prove or rule out asthma?
- What history, quality check, or follow-up test would change your confidence?
- Case A: FEV₁ rises from 1.70 L to 1.95 L.
- Case B: FEV₁ rises from 2.80 L to 3.05 L.
- Case C: FEV₁ rises from 1.50 L to 1.66 L.
The key is not just the arithmetic. Case A gains 250 mL and 14.7%, so it meets both thresholds and supports asthma if the symptoms are typical. Case B gains 250 mL but only 8.9%, so it fails the percentage requirement. Case C gains 10.7% but only 160 mL, so it fails the volume requirement. Cases B and C are nondiagnostic—not proof against asthma.
The next day, repeat the exercise with different baseline values but the same absolute change. Then explain aloud why the percentage changes. That single variation targets the denominator error more effectively than rereading a definition.
Practical takeaways
- For the common adult asthma framework, a positive bronchodilator response requires both an increase of at least 12% and at least 200 mL in FEV₁ or FVC from baseline.
- Calculate the percentage from the pre-bronchodilator value.
- A positive response supports variable airflow limitation and can support asthma only in the appropriate clinical context.
- A negative response does not exclude asthma, especially when symptoms are intermittent or the test conditions were suboptimal.
- On board questions, separate the calculation, the diagnostic meaning, and the next clinical decision instead of treating them as one step.
